DK0572537T3 - Cytokinnhibitorer - Google Patents

Cytokinnhibitorer

Info

Publication number
DK0572537T3
DK0572537T3 DK92907362T DK92907362T DK0572537T3 DK 0572537 T3 DK0572537 T3 DK 0572537T3 DK 92907362 T DK92907362 T DK 92907362T DK 92907362 T DK92907362 T DK 92907362T DK 0572537 T3 DK0572537 T3 DK 0572537T3
Authority
DK
Denmark
Prior art keywords
production
inhibiting
cytokine inhibitors
mammal
interleukin
Prior art date
Application number
DK92907362T
Other languages
English (en)
Inventor
Alison Mary Badger
Wanda Bernadette High
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Application granted granted Critical
Publication of DK0572537T3 publication Critical patent/DK0572537T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK92907362T 1991-02-19 1992-02-18 Cytokinnhibitorer DK0572537T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65757891A 1991-02-19 1991-02-19
PCT/US1992/001283 WO1992014462A1 (en) 1991-02-19 1992-02-18 Cytokine inhibitors

Publications (1)

Publication Number Publication Date
DK0572537T3 true DK0572537T3 (da) 2000-03-27

Family

ID=24637788

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92907362T DK0572537T3 (da) 1991-02-19 1992-02-18 Cytokinnhibitorer

Country Status (14)

Country Link
US (2) US5602166A (da)
EP (1) EP0572537B1 (da)
JP (1) JP3162071B2 (da)
KR (1) KR930702975A (da)
AT (1) ATE186641T1 (da)
AU (1) AU657745B2 (da)
CA (1) CA2104214C (da)
DE (1) DE69230314T2 (da)
DK (1) DK0572537T3 (da)
ES (1) ES2138595T3 (da)
GR (1) GR3032612T3 (da)
IE (1) IE920508A1 (da)
WO (1) WO1992014462A1 (da)
ZA (1) ZA921120B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201803D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9201804D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
GB9414902D0 (en) * 1994-07-23 1994-09-14 Smithkline Beecham Corp Methods
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
WO1997002820A1 (en) * 1995-07-13 1997-01-30 Anormed Inc. N,n-dimethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate
BR9709007A (pt) * 1996-05-17 2000-01-04 Anormed Inc Uso de azaspirano substituìdo no tratamento da asma.
GB2309167A (en) * 1997-05-10 1997-07-23 Anormed Inc The use of azaspiranes in the treatment of Alzheimer's disease
CO5190696A1 (es) * 1999-06-16 2002-08-29 Smithkline Beecham Corp Antagonistas de los receptores il-8
CO5200760A1 (es) * 1999-06-16 2002-09-27 Smithkline Beecham Corp Antagonistas del receptor de la il-8 ceptor il-8
US6184246B1 (en) 1999-07-30 2001-02-06 The United States Of America As Represented By The Secretary Of Agriculture Inhibition of cytokine production by polymethoxylated flavones
WO2002080970A1 (en) * 2001-03-23 2002-10-17 Regents Of The University Of California Method for inhibiting articular cartilage matrix calcification
US7674838B2 (en) * 2002-04-05 2010-03-09 Henkel Corporation Curable foam elastomeric compositions
CA2518357A1 (en) * 2003-03-10 2004-09-23 Callisto Pharmaceuticals, Inc. Method of treating cancer with azaspirane compositions
US20100203146A1 (en) * 2009-02-09 2010-08-12 Callisto Pharmaceuticals, Inc. Intermittent dosing strategy for treating rheumatoid arthritis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3106552A (en) 1960-07-19 1963-10-08 Geschickter Fund Med Res Nu-substituted azaspiranes and azaspirane-diones and processes for their preparation
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
BR8907457A (pt) 1988-05-27 1991-04-02 Synergen Inc Inibidores de interleucina-1

Also Published As

Publication number Publication date
ZA921120B (en) 1993-01-27
EP0572537A1 (en) 1993-12-08
AU1463392A (en) 1992-09-15
JPH06505483A (ja) 1994-06-23
IE920508A1 (en) 1992-08-26
WO1992014462A1 (en) 1992-09-03
ATE186641T1 (de) 1999-12-15
AU657745B2 (en) 1995-03-23
DE69230314D1 (de) 1999-12-23
GR3032612T3 (en) 2000-05-31
US5900430A (en) 1999-05-04
DE69230314T2 (de) 2000-02-24
KR930702975A (ko) 1993-11-29
EP0572537A4 (en) 1993-10-14
CA2104214A1 (en) 1992-08-20
JP3162071B2 (ja) 2001-04-25
ES2138595T3 (es) 2000-01-16
CA2104214C (en) 2004-04-27
EP0572537B1 (en) 1999-11-17
US5602166A (en) 1997-02-11

Similar Documents

Publication Publication Date Title
ATE186641T1 (de) Cytokinhemmer
NO942618L (no) Imidazolderivater og deres anvendelse som cytokin-inhibitorer
IL135068A0 (en) Stimulation of hematopoietic cells in vitro
FI981437L (fi) PDE III, PDE IV ja TNF inhibiittoreina käyttökelpoisia imidejä
ES2192227T3 (es) Composiciones farmaceuticas orales con liberacion retardada de inhibidores reversibles de las bombas de protones.
EP0715619A4 (en) Inhibitors of tnf-alpha secretion
NO326660B1 (no) Imidazolyl-cykliske acetal forbindelser, farmasøytiske sammensetninger inneholdende disse forbindelser og anvendelse av forbindelsene
FI904450A7 (fi) Uusia peptidaasi- ja isomeraasi-inhibiittoreita
DK0912192T3 (da) Administration af GM-CSF til behandling af hjernetumorer og forebyggelse af sådanne tumorers tilbagevenden
DK0527879T3 (da) Synergistiske terapeutiske præparater og fremgangsmåder.
ATE252885T1 (de) Plan zur verabreichung von h+, k+-atpase inhibitoren
EA200200808A1 (ru) Модифицированные цитокины, предназначенные для применения в терапии рака
MX9205875A (es) Compuestos.
ATE346041T1 (de) N-hydroxyformamid-derivate
GB8907305D0 (en) High slew rate linear amplifier
KR950703064A (ko) 세포증식의 저해물질, 그의 제조방법 및 이용방법
ES2120962T3 (es) Composicion antivirica.
NO890046L (no) Disubstituerte pyridiner.
IT8420506U1 (it) Dispositivo di regolazione e di posizionamento per una poltrona.
ATE59553T1 (de) Polyhydroxybenzoesaeure-abkoemmlinge.
ITTO910787A0 (it) Amplificatore di potenza, in particolare di tipo audio
FI962264A0 (fi) Tulehduksia aiheuttavan sytokiinin muodostumisen inhibiittori, joka käsittää polyprenyylin johdannaisia aktiivisena ainesosana
EA199900579A1 (ru) Применение ингибиторов комт для производства лекарственного средства для профилактики сосудистых дисфункций при диабете
ES2078501T3 (es) Metodo para el tratamiento de la trombocitopenia y composiciones farmaceuticas utiles para el mismo.
FI914776A7 (fi) Inhibiittoreita kasvainkuoliotekijän muodostumiselle, menetelmä niidenvalmistamiseksi ja niiden käyttö